Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
radiopharmaceuticals
Biotech
Pentixapharm scores $22M in IPO to advance radiopharma trials
The stock debuted on the Frankfurt Stock Exchange this morning at 5.10 euros per share, resulting in a market capitalization of 126.5 million euros.
James Waldron
Oct 3, 2024 10:36am
Big Pharma backers return for Aktis' $175M series B
Sep 30, 2024 8:00am
Sanofi pays $110M upfront for late-stage radioligand therapy
Sep 12, 2024 4:54am
Siemens Healthineers buys Novartis' EU radiodiagnostic network
Aug 26, 2024 11:30am
SK inks $572M deal for Full-Life radiopharma prospect
Jul 17, 2024 9:18am
Lantheus acquires Alzheimer’s PET diagnostic developer Meilleur
Jul 15, 2024 11:30am